D-0127-2024 Class III Terminated
FDA drug recall D-0127-2024 was initiated by Teva Pharmaceuticals USA, Inc on Nov 10, 2023 and is designated Class III. Reason for recall: OOS for viscosity The recall status is terminated (terminated Jun 3, 2024).
Recall details
- Product Type
- Drugs
- Report Date
- Dec 6, 2023
- Initiation Date
- Nov 10, 2023
- Termination Date
- Jun 3, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Testosterone Gel, 1.62% CIII (Alcohol 80% v/v), packaged in 30 unit-dose packets per carton, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0591-2926-30
Reason for recall
OOS for viscosity
Distribution pattern
USA nationwide
Code information
Lot #: 100029472, Exp. 2/29/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0127-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026